Work

Safety and efficacy of a DKK1 inhibitor (DKN-01) as monotherapy or in combination with paclitaxel in patients with Wnt activated recurrent gynecologic malignancies

Year: 2019

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.04.080

Authors: R.C. Arend, C.M. Castro, U.A. Matulonis, E. Hamilton, C.C. Gunderson, K.S.S. Lybarger, M. Kagey, C. Sirard, M.J. Birrer

Institutions: University of Alabama at Birmingham, Massachusetts General Hospital, Dana-Farber Cancer Institute, Sarah Cannon, Tennessee Oncology, University of Oklahoma Health Sciences Center, University of Missouri–Kansas City, Leap Therapeutics, Inc. (United States)

Language: English

Topic: Wnt/β-catenin signaling in development and cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955212280

FWCI: 0.415

Cites:

Cited by: 7

Related to: 10